Please login to the form below

Not currently logged in
Email:
Password:

Dr Vytenis Andriukaitis

This page shows the latest Dr Vytenis Andriukaitis news and features for those working in and with pharma, biotech and healthcare.

A baptism of fire for Europe's new health commissioner

A baptism of fire for Europe's new health commissioner

Controversial trade deals, the spread of Ebola and the threat of austerity are just three of the issues facing Dr Vytenis Andriukaitis. ... A former health minister for Lithuania Dr Vytenis Andriukaitis is no stranger to hardship, having spent the first

Latest news

  • EC: medicines to remain part of health directorate EC: medicines to remain part of health directorate

    Instead medicines will remain under control of the Directorate General for Health and Consumers, whose Commissioner is now Vytenis Andriukaitis after the recent reshuffle of EC ministers. ... Dr Vytenis Andriukaitis will now have the tools to fulfil his

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • A healthy challenge A healthy challenge

    The EC’s Dr Vytenis Andriukaitis on Europe’s problems with health. Europe is not alone in facing challenges from an ageing population, but as the EU's citizens live longer ... Someone with a particularly keen interest in public health is the European

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New EC health director general takes office New EC health director general takes office

    XavierPrats Monné will report to health commissioner Dr Vytenis Andriukaitis. The European Commission's health and food safety directorate has a new director general, with Xavier Prats Monné taking over from ... In his new role Prats Monné will report

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....